Development and trends of surgical modalities for breast cancer in China: a review of 16-year data
Surgery is the most important treatment for nonmetastatic breast cancer; however, the utilization of modern surgical techniques in management of breast cancer in mainland China has not been reported. The medical records of 5887 consecutive breast cancer patients treated surgically in the past 16 yea...
Gespeichert in:
Veröffentlicht in: | Annals of surgical oncology 2007-09, Vol.14 (9), p.2502-2509 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2509 |
---|---|
container_issue | 9 |
container_start_page | 2502 |
container_title | Annals of surgical oncology |
container_volume | 14 |
creator | Yu, Ke-Da Di, Gen-Hong Wu, Jiong Lu, Jin-Song Shen, Kun-Wei Shen, Zhen-Zhou Shao, Zhi-Min |
description | Surgery is the most important treatment for nonmetastatic breast cancer; however, the utilization of modern surgical techniques in management of breast cancer in mainland China has not been reported.
The medical records of 5887 consecutive breast cancer patients treated surgically in the past 16 years were reviewed retrospectively; the utilization of different surgical modalities and associated clinical outcomes were analyzed.
Median age of all patients was 50 (range 16-92). About 1015 patients were staged as 0-I, 3569 stage II, 517 stage III, and 786 cases could not be staged. Extensive radical mastectomy (ERM), radical mastectomy (RM), modified radical mastectomy (MRM), simple mastectomy (SM), and breast-conserving surgery (BCS) were used in 8%, 27.2%, 55.7%, 1.5%, and 6.3% of patients, respectively. In addition, 1.3% of patients received breast reconstruction. The proportion of early-stage breast cancer increased, and the surgery patterns varied. MRM gradually replaced ERM and RM. The prevalence of BCS began to increase from the mid-1990s and currently represents about 12%. The prevalence of reconstruction also increased and now accounts for 5%. Age, pathologic pattern, and TNM staging affected the choice of surgery modalities markedly. Although patients receiving RM/ERM had worse survival than those receiving BCS/MRM, the survival outcomes of these four groups were similar in the early-stage population.
MRM remains the most-used surgical modality in operable breast cancer, although the utilization of BCS for early-stage disease has increased rapidly in last decade. Reconstruction following mastectomy as an alternative to BCS is available. Breast-conserving therapy (BCT) and MRM provide similar local controls and long-term survival for breast cancer. Selection of appropriate candidates for a certain surgery requires an assessment of the patient's age and clinical and pathological characteristics of the tumor. |
doi_str_mv | 10.1245/s10434-007-9436-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68256772</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1335793071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-71ceea9cac32f0264d234b5f745ac22411293a164c31ffaac92bcebbe06c54593</originalsourceid><addsrcrecordid>eNpdkMlKA0EQhhtRjEYfwIs0Hry19t4ZbxJXCHjRc1PTU6MTZondM5G8vRMSEDzVwlc_xUfIheA3QmpzmwTXSjPOHcu0skwekBNhxo22M3E49tzOWCatmZDTlJacC6e4OSYT4YzVzvATkj_gGutu1WDbU2gL2kdsi0S7kqYhflYBatp0BdRVX2GiZRdpHhFSTwO0ASOtWjr_qlq4o0Ajriv82d4KyzYIkRbQwxk5KqFOeL6vU_Lx9Pg-f2GLt-fX-f2CBSVtz5wIiJAFGMeSS6sLqXRuSqcNBCm1EDJTIKwOSpQlQMhkHjDPkdtgtMnUlFzvclex-x4w9b6pUsC6hha7IXk7k8Y6J0fw6h-47IbYjr95KZ0yRmRqhMQOCrFLKWLpV7FqIG684H5r3-_s-9G-39r32-DLffCQN1j8Xex1q1-duH8t</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227355193</pqid></control><display><type>article</type><title>Development and trends of surgical modalities for breast cancer in China: a review of 16-year data</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Yu, Ke-Da ; Di, Gen-Hong ; Wu, Jiong ; Lu, Jin-Song ; Shen, Kun-Wei ; Shen, Zhen-Zhou ; Shao, Zhi-Min</creator><creatorcontrib>Yu, Ke-Da ; Di, Gen-Hong ; Wu, Jiong ; Lu, Jin-Song ; Shen, Kun-Wei ; Shen, Zhen-Zhou ; Shao, Zhi-Min</creatorcontrib><description>Surgery is the most important treatment for nonmetastatic breast cancer; however, the utilization of modern surgical techniques in management of breast cancer in mainland China has not been reported.
The medical records of 5887 consecutive breast cancer patients treated surgically in the past 16 years were reviewed retrospectively; the utilization of different surgical modalities and associated clinical outcomes were analyzed.
Median age of all patients was 50 (range 16-92). About 1015 patients were staged as 0-I, 3569 stage II, 517 stage III, and 786 cases could not be staged. Extensive radical mastectomy (ERM), radical mastectomy (RM), modified radical mastectomy (MRM), simple mastectomy (SM), and breast-conserving surgery (BCS) were used in 8%, 27.2%, 55.7%, 1.5%, and 6.3% of patients, respectively. In addition, 1.3% of patients received breast reconstruction. The proportion of early-stage breast cancer increased, and the surgery patterns varied. MRM gradually replaced ERM and RM. The prevalence of BCS began to increase from the mid-1990s and currently represents about 12%. The prevalence of reconstruction also increased and now accounts for 5%. Age, pathologic pattern, and TNM staging affected the choice of surgery modalities markedly. Although patients receiving RM/ERM had worse survival than those receiving BCS/MRM, the survival outcomes of these four groups were similar in the early-stage population.
MRM remains the most-used surgical modality in operable breast cancer, although the utilization of BCS for early-stage disease has increased rapidly in last decade. Reconstruction following mastectomy as an alternative to BCS is available. Breast-conserving therapy (BCT) and MRM provide similar local controls and long-term survival for breast cancer. Selection of appropriate candidates for a certain surgery requires an assessment of the patient's age and clinical and pathological characteristics of the tumor.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-007-9436-2</identifier><identifier>PMID: 17564750</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms - epidemiology ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Chi-Square Distribution ; China - epidemiology ; Female ; Humans ; Incidence ; Mastectomy - methods ; Mastectomy - trends ; Middle Aged ; Neoplasm Staging ; Practice Patterns, Physicians' - statistics & numerical data ; Retrospective Studies ; Survival Analysis ; Treatment Outcome</subject><ispartof>Annals of surgical oncology, 2007-09, Vol.14 (9), p.2502-2509</ispartof><rights>Society of Surgical Oncology 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-71ceea9cac32f0264d234b5f745ac22411293a164c31ffaac92bcebbe06c54593</citedby><cites>FETCH-LOGICAL-c326t-71ceea9cac32f0264d234b5f745ac22411293a164c31ffaac92bcebbe06c54593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17564750$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Ke-Da</creatorcontrib><creatorcontrib>Di, Gen-Hong</creatorcontrib><creatorcontrib>Wu, Jiong</creatorcontrib><creatorcontrib>Lu, Jin-Song</creatorcontrib><creatorcontrib>Shen, Kun-Wei</creatorcontrib><creatorcontrib>Shen, Zhen-Zhou</creatorcontrib><creatorcontrib>Shao, Zhi-Min</creatorcontrib><title>Development and trends of surgical modalities for breast cancer in China: a review of 16-year data</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><description>Surgery is the most important treatment for nonmetastatic breast cancer; however, the utilization of modern surgical techniques in management of breast cancer in mainland China has not been reported.
The medical records of 5887 consecutive breast cancer patients treated surgically in the past 16 years were reviewed retrospectively; the utilization of different surgical modalities and associated clinical outcomes were analyzed.
Median age of all patients was 50 (range 16-92). About 1015 patients were staged as 0-I, 3569 stage II, 517 stage III, and 786 cases could not be staged. Extensive radical mastectomy (ERM), radical mastectomy (RM), modified radical mastectomy (MRM), simple mastectomy (SM), and breast-conserving surgery (BCS) were used in 8%, 27.2%, 55.7%, 1.5%, and 6.3% of patients, respectively. In addition, 1.3% of patients received breast reconstruction. The proportion of early-stage breast cancer increased, and the surgery patterns varied. MRM gradually replaced ERM and RM. The prevalence of BCS began to increase from the mid-1990s and currently represents about 12%. The prevalence of reconstruction also increased and now accounts for 5%. Age, pathologic pattern, and TNM staging affected the choice of surgery modalities markedly. Although patients receiving RM/ERM had worse survival than those receiving BCS/MRM, the survival outcomes of these four groups were similar in the early-stage population.
MRM remains the most-used surgical modality in operable breast cancer, although the utilization of BCS for early-stage disease has increased rapidly in last decade. Reconstruction following mastectomy as an alternative to BCS is available. Breast-conserving therapy (BCT) and MRM provide similar local controls and long-term survival for breast cancer. Selection of appropriate candidates for a certain surgery requires an assessment of the patient's age and clinical and pathological characteristics of the tumor.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Chi-Square Distribution</subject><subject>China - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Mastectomy - methods</subject><subject>Mastectomy - trends</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Practice Patterns, Physicians' - statistics & numerical data</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkMlKA0EQhhtRjEYfwIs0Hry19t4ZbxJXCHjRc1PTU6MTZondM5G8vRMSEDzVwlc_xUfIheA3QmpzmwTXSjPOHcu0skwekBNhxo22M3E49tzOWCatmZDTlJacC6e4OSYT4YzVzvATkj_gGutu1WDbU2gL2kdsi0S7kqYhflYBatp0BdRVX2GiZRdpHhFSTwO0ASOtWjr_qlq4o0Ajriv82d4KyzYIkRbQwxk5KqFOeL6vU_Lx9Pg-f2GLt-fX-f2CBSVtz5wIiJAFGMeSS6sLqXRuSqcNBCm1EDJTIKwOSpQlQMhkHjDPkdtgtMnUlFzvclex-x4w9b6pUsC6hha7IXk7k8Y6J0fw6h-47IbYjr95KZ0yRmRqhMQOCrFLKWLpV7FqIG684H5r3-_s-9G-39r32-DLffCQN1j8Xex1q1-duH8t</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>Yu, Ke-Da</creator><creator>Di, Gen-Hong</creator><creator>Wu, Jiong</creator><creator>Lu, Jin-Song</creator><creator>Shen, Kun-Wei</creator><creator>Shen, Zhen-Zhou</creator><creator>Shao, Zhi-Min</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20070901</creationdate><title>Development and trends of surgical modalities for breast cancer in China: a review of 16-year data</title><author>Yu, Ke-Da ; Di, Gen-Hong ; Wu, Jiong ; Lu, Jin-Song ; Shen, Kun-Wei ; Shen, Zhen-Zhou ; Shao, Zhi-Min</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-71ceea9cac32f0264d234b5f745ac22411293a164c31ffaac92bcebbe06c54593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Chi-Square Distribution</topic><topic>China - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Mastectomy - methods</topic><topic>Mastectomy - trends</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Practice Patterns, Physicians' - statistics & numerical data</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Ke-Da</creatorcontrib><creatorcontrib>Di, Gen-Hong</creatorcontrib><creatorcontrib>Wu, Jiong</creatorcontrib><creatorcontrib>Lu, Jin-Song</creatorcontrib><creatorcontrib>Shen, Kun-Wei</creatorcontrib><creatorcontrib>Shen, Zhen-Zhou</creatorcontrib><creatorcontrib>Shao, Zhi-Min</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Ke-Da</au><au>Di, Gen-Hong</au><au>Wu, Jiong</au><au>Lu, Jin-Song</au><au>Shen, Kun-Wei</au><au>Shen, Zhen-Zhou</au><au>Shao, Zhi-Min</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and trends of surgical modalities for breast cancer in China: a review of 16-year data</atitle><jtitle>Annals of surgical oncology</jtitle><addtitle>Ann Surg Oncol</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>14</volume><issue>9</issue><spage>2502</spage><epage>2509</epage><pages>2502-2509</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Surgery is the most important treatment for nonmetastatic breast cancer; however, the utilization of modern surgical techniques in management of breast cancer in mainland China has not been reported.
The medical records of 5887 consecutive breast cancer patients treated surgically in the past 16 years were reviewed retrospectively; the utilization of different surgical modalities and associated clinical outcomes were analyzed.
Median age of all patients was 50 (range 16-92). About 1015 patients were staged as 0-I, 3569 stage II, 517 stage III, and 786 cases could not be staged. Extensive radical mastectomy (ERM), radical mastectomy (RM), modified radical mastectomy (MRM), simple mastectomy (SM), and breast-conserving surgery (BCS) were used in 8%, 27.2%, 55.7%, 1.5%, and 6.3% of patients, respectively. In addition, 1.3% of patients received breast reconstruction. The proportion of early-stage breast cancer increased, and the surgery patterns varied. MRM gradually replaced ERM and RM. The prevalence of BCS began to increase from the mid-1990s and currently represents about 12%. The prevalence of reconstruction also increased and now accounts for 5%. Age, pathologic pattern, and TNM staging affected the choice of surgery modalities markedly. Although patients receiving RM/ERM had worse survival than those receiving BCS/MRM, the survival outcomes of these four groups were similar in the early-stage population.
MRM remains the most-used surgical modality in operable breast cancer, although the utilization of BCS for early-stage disease has increased rapidly in last decade. Reconstruction following mastectomy as an alternative to BCS is available. Breast-conserving therapy (BCT) and MRM provide similar local controls and long-term survival for breast cancer. Selection of appropriate candidates for a certain surgery requires an assessment of the patient's age and clinical and pathological characteristics of the tumor.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>17564750</pmid><doi>10.1245/s10434-007-9436-2</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1068-9265 |
ispartof | Annals of surgical oncology, 2007-09, Vol.14 (9), p.2502-2509 |
issn | 1068-9265 1534-4681 |
language | eng |
recordid | cdi_proquest_miscellaneous_68256772 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adolescent Adult Aged Aged, 80 and over Breast Neoplasms - epidemiology Breast Neoplasms - pathology Breast Neoplasms - surgery Chi-Square Distribution China - epidemiology Female Humans Incidence Mastectomy - methods Mastectomy - trends Middle Aged Neoplasm Staging Practice Patterns, Physicians' - statistics & numerical data Retrospective Studies Survival Analysis Treatment Outcome |
title | Development and trends of surgical modalities for breast cancer in China: a review of 16-year data |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T01%3A19%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20trends%20of%20surgical%20modalities%20for%20breast%20cancer%20in%20China:%20a%20review%20of%2016-year%20data&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Yu,%20Ke-Da&rft.date=2007-09-01&rft.volume=14&rft.issue=9&rft.spage=2502&rft.epage=2509&rft.pages=2502-2509&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-007-9436-2&rft_dat=%3Cproquest_cross%3E1335793071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227355193&rft_id=info:pmid/17564750&rfr_iscdi=true |